AMRX
Price
$11.52
Change
-$0.05 (-0.43%)
Updated
Nov 19, 01:56 PM (EDT)
Capitalization
3.64B
105 days until earnings call
Intraday BUY SELL Signals
PRFX
Price
$0.83
Change
-$0.01 (-1.19%)
Updated
Nov 19, 01:36 PM (EDT)
Capitalization
1.68M
Intraday BUY SELL Signals
Interact to see
Advertisement

AMRX vs PRFX

Header iconAMRX vs PRFX Comparison
Open Charts AMRX vs PRFXBanner chart's image
Amneal Pharmaceuticals
Price$11.52
Change-$0.05 (-0.43%)
Volume$749
Capitalization3.64B
PainReform
Price$0.83
Change-$0.01 (-1.19%)
Volume$2.03K
Capitalization1.68M
AMRX vs PRFX Comparison Chart in %
AMRX
Daily Signal:
Gain/Loss:
PRFX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMRX vs. PRFX commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (AMRX: $11.57 vs. PRFX: $0.84)
Brand notoriety: AMRX and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMRX: 61% vs. PRFX: 11%
Market capitalization -- AMRX: $3.64B vs. PRFX: $1.68M
AMRX [@Pharmaceuticals: Generic] is valued at $3.64B. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $1.68M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while PRFX’s TA Score has 4 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 4 bearish.
  • PRFX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AMRX and PRFX are a good buy in the short-term.

Price Growth

AMRX (@Pharmaceuticals: Generic) experienced а -3.14% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -5.64% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.86%. For the same industry, the average monthly price growth was -6.64%, and the average quarterly price growth was +28.04%.

Reported Earning Dates

AMRX is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.86% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($3.64B) has a higher market cap than PRFX($1.69M). AMRX has higher P/E ratio than PRFX: AMRX (1159.00) vs PRFX (0.03). AMRX YTD gains are higher at: 46.149 vs. PRFX (-75.052). AMRX has higher annual earnings (EBITDA): 584M vs. PRFX (-17.81M). PRFX has less debt than AMRX: PRFX (59K) vs AMRX (2.58B). AMRX has higher revenues than PRFX: AMRX (2.85B) vs PRFX (0).
AMRXPRFXAMRX / PRFX
Capitalization3.64B1.69M215,964%
EBITDA584M-17.81M-3,279%
Gain YTD46.149-75.052-61%
P/E Ratio1159.000.034,140,321%
Revenue2.85B0-
Total Cash71.5MN/A-
Total Debt2.58B59K4,376,271%
FUNDAMENTALS RATINGS
AMRX: Fundamental Ratings
AMRX
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
13
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMRXPRFX
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 24 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signal:
Gain/Loss:
PRFX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JEF53.230.74
+1.41%
Jefferies Financial Group
CIVB21.18-0.19
-0.89%
Civista Bancshares
BWIN26.75-1.23
-4.38%
The Baldwin Insurance Group Inc.
ATHE3.60-0.19
-5.12%
Alterity Therapeutics Limited
ECDA0.67-0.04
-5.99%
ECD Automotive Design Inc.

PRFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRFX has been loosely correlated with SILFF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PRFX jumps, then SILFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
-5.30%
SILFF - PRFX
36%
Loosely correlated
N/A
EVOK - PRFX
24%
Poorly correlated
+0.05%
AMRX - PRFX
24%
Poorly correlated
-0.04%
SEHCF - PRFX
23%
Poorly correlated
N/A
LFCR - PRFX
21%
Poorly correlated
-4.18%
More